$7.46
-0.45-6.03%
At close: Oct 31, 12:31 PM EDT
$7.34
-0.12-1.61%
After Hours: Oct 29, 7:29 PM EDT
15 minutes delayed
Comments
Loading...
Galecto (NASDAQ:GLTO) Stock Quotes, Forecast and News Summary
Galecto Stock (NASDAQ: GLTO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Galecto (GLTO) stock?
You can purchase shares of Galecto (NASDAQ:GLTO) through any online brokerage.
Who are Galecto (GLTO) competitors?
Other companies in Galecto’s space includes: Vincerx Pharma (NASDAQ:VINC), NKGen Biotech (NASDAQ:NKGN), Immuron (NASDAQ:IMRN), Coeptis Therapeutics (NASDAQ:COEP) and BioRestorative Therapies (NASDAQ:BRTX).
What is the forecast, or price target, for Galecto (GLTO) stock?
Galecto has a consensus price target of $8.50.
What is the current price for Galecto (GLTO)?
The stock price for Galecto (NASDAQ: GLTO) is $7.01 last updated October 31, 2024 at 12:31 PM EDT.
Does Galecto (GLTO) pay a dividend?
There are no upcoming dividends for Galecto.
When is Galecto (NASDAQ:GLTO) reporting earnings?
Galecto’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Galecto (GLTO) going to split?
There is no upcoming split for Galecto.
What sector and industry does Galecto (GLTO) operate in?
Galecto is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.